Effects of the association of dual-site dynamic atrial overdrive and atenolol in preventing recurrent atrial fibrillation;Efeitos da associação da estimulação atrial dinâmica em duplo sítio atrial com atenolol na prevenç ão da fibrilação atrial recorrente

Arquivos Brasileiros de Cardiologia

Volumn 88, Issue 1, 2007, Pages 1-7

  Menezes Jr , Antonio Da Silva ^a   Martinelli Filho, Martino ^b,d   Menezes, Carlos Cléber Dos Santos ^c   Costa, Roberto ^b   Ramires, José Antônio Franchini ^b  

^a Hospital São Francisco de Assis   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Hospital São Lucas de Curitiba   (Brazil)

^d NONE   (Brazil)

Author keywords

Dual site atrial pacemaker; Dynamic atrial overdrive; Prevention of atrial fibrillation; Recurrent atrial fibrillation

Indexed keywords

ANTICOAGULANT AGENT; ATENOLOL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR SYMPTOM; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART RATE; HOLTER MONITORING; HOSPITAL ADMISSION; HUMAN; MALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SCORING SYSTEM; SHORT FORM 36; SINGLE BLIND PROCEDURE; SINUS NODE DISEASE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANTI-ARRHYTHMIA AGENTS; ATENOLOL; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; COMBINED MODALITY THERAPY; CROSS-OVER STUDIES; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECURRENCE; SICK SINUS SYNDROME; SINGLE-BLIND METHOD; TIME FACTORS;

EID: 33947319500     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2007000100001     Document Type: Article

References (12)

1. Kannel WB, Abbot RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 1982; 306:1018-22.
2. Nattel S, Hadjis T, Talajic M. The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations. Drugs 1994;48:345-71.
3. Wijffels MC, Kirchhof CJ, Dorland R, Power J, Alessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 1995;92: 1954-68.
4. Rensma PL, Alessie MA, Lammers WJEP, Bonke FIM, Schaly MJ. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dog. Circ Res 1988; 62:395-410.
5. Wang Z, Page PL, Nattel S. Mechanism of flecained's antiarrhythmic action in experimental atrial fibrillation. Circ Res 1992;71:271-87.
6. Gaspo R, Bosch RF, Tajalic M, Nattel S. Functional mechanisms underlying tachycardia - induced sustained atrial fibrillation in a chronic dog model. Circulation 1997;96:4027-35.
7. Jayachandran JV, Zipes DP, Weksler J, et al. Role of the Na+/H+ exhanger in short-term atrial electrophysiological remodeling. Circulation 2000;12:766-9.
8. Carlson MD, Ip I, Messenger J, et al. A new pacemaker algorithm for the treatment of atrial fibrillation. Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003;42:627-33.
9. Ramdat MAR, Beukema WP, Luttikhuis OHA, et al. Multisite atrial pacing: an option for atrial fibrillation prevention? Preliminary results of the Dutch dual-site right atrial pacing for prevention of atrial fibrillation study. Am J Cardiol 2000;86:K20-K24.
10. Saksena S, Delfault P, Prakash A, Kaushik RR, Krol RB. Multisite Electrode Pacing for Prevention of Atrial Fibrillation. J Cardiovasc Electrophysiol 2000;9:S155-S162.
11. Funck RC, Adamec R, Lurje L, et al. Atrial overdrive is beneficial in patients with atrial arrhythmias: First results of the PROVE study. Pacing Clin Electrophysiol 2000;23:1891-3.
12. Senatore O, De Simone A, Stabile G, Mininno A, Maddalon M. Stadim - dynamic atrial pacing and multisite atrial pacing in the prevention of AF. Europace 2001;2(Suppl): B38.